Reuters logo
BUZZ-Amicus Therapeutics: On track to report trial data
June 30, 2014 / 2:35 PM / 3 years ago

BUZZ-Amicus Therapeutics: On track to report trial data

** The drugmaker’s shares up 28 pct at $3.88

** Says on track to report data from a late-stage trial of its genetic disorder drug in the third quarter of this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below